Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Totaligent ( (TGNT) ).
On March 4, 2026, Totaligent, Inc. signed an amendment extending the timeline of its February 11, 2026 binding letter of intent to acquire Aetherium Medical’s team, business plan, intellectual property, know-how, contacts and related assets in an equity-for-assets acqui-hire transaction. The target dates for negotiating and executing definitive agreements, as well as closing the transaction, were moved from March 5, 2026, to March 20, 2026, while the exclusivity period through April 5, 2026, and all other LOI terms remain in force, indicating continued commitment to the deal as the parties complete negotiations and due diligence.
More about Totaligent
Totaligent, Inc. is a company pursuing an acqui-hire of Aetherium Medical, aiming to integrate Aetherium’s team, business plan, intellectual property, know-how, contacts and related assets in exchange for equity. The contemplated transaction suggests a strategic focus on expanding capabilities and assets in the medical or healthcare-related technology space through equity-based acquisition.
Average Trading Volume: 51,673
Technical Sentiment Signal: Sell
Current Market Cap: $3.02M
Learn more about TGNT stock on TipRanks’ Stock Analysis page.